[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Search Powered by Google
 

Patient Information Sheet
Temozolomide (marketed as Temodar)

Temodar®
Brand Name: Temodar
Active Ingredient:   temozolomide
Strength(s): 5mg, 20mg, 100mg, & 250mg
Dosage Form(s):   Capsules
Company Name:    Schering Corporation
Availability:         Prescription only
*Date Approved by FDA:   August 11, 1999
*Approval by FDA does not mean that the drug is available to consumers at this time.

What is Temodar used for?

Temodar is used to treat a form of brain cancer (anaplastic astrocytoma) in adults whose disease progressed after radiation therapy and chemotherapy with nitrosoureas and procarbazine, drugs commonly used to treat brain cancers.

Temodar is used to treat adults newly diagnosed with a form of brain cancer (glioblastoma multiforme) while also being treated with radiotherapy and then used as a maintenance treatment.

At this time, it is not known whether Temodar will improve symptoms, keep the disease from getting worse, or help patients live longer.

Who should not take Temodar?

You should not take Temodar if you have had an allergic reaction to dacarbazine, another drug used to treat cancer, because you may have a similar reaction while taking Temodar.

General Precautions with Temodar: 

Read the patient information that comes with Temodar before you start taking it and every time you renew your prescription in case the information has been updated.

Temodar can cause a decrease in the body’s ability to produce bone marrow (myelosuppression), which is needed to form several components of the blood. Your doctor will check you for this condition while you are being treated with Temodar.

If you have a history of severe liver or kidney problems your doctor will evaluate and decide if Temodar is right for you.

Because Temodar can cause birth defects, women should avoid becoming pregnant and stop breast-feeding a baby and nursing while taking Temodar. Tell your healthcare provider if you are already pregnant or are breast-feeding. Men and women taking Temodar should use effective birth control.

Keep this medicine away from children and pets.

What should I tell my doctor or healthcare provider?

Because certain other medications can interact with Temodar, review all medications that you are taking with your healthcare provider, including those that you take without a prescription.

Because Temodar can cause birth defects, women should avoid becoming pregnant and stop breast-feeding a baby and nursing while taking Temodar. Tell your healthcare provider if you are already pregnant or are breast-feeding. Men and women taking Temodar should use effective birth control.

What are some possible side effects of Temodar? (This is NOT a complete list of side effects reported with Temodar. Your healthcare provider can discuss with you a more complete list of side effects.)  

Some possible side effects are:

·         Nausea

·         Vomiting

·         Headache

·         Tiredness

·         Constipation

·         Low blood count

 

Other side effects include:

  • Weakness

  • Memory loss

  • Drowsiness

  • Back pain

  • Fever

  • Diarrhea

  • Itching

  • Dizziness

  • Swelling in arms or legs

  • Tingling or burning feeling

  • Stomach pain

  • Loss of appetite

  • Anxiety

For more detailed information about Temodar, ask your healthcare provider.

Link to Temodar’s Approved Labeling and Patient Information 

 Back to Entry Page

 PDF requires the free Adobe Acrobat Reader

Back to Top     Back to Drug Index

Date created:  November 22, 1999, Updated:  July, 11, 2001, August, 2005

horizonal rule